MEDNAX (MD) Reports In-Line Q1 EPS, provides outlook

MEDNAX (NYSE: MD) reported Q1 EPS of $0.20, in-line with the analyst estimate of $0.20. Revenue for the quarter came in at $495 million versus the consensus estimate of $500.5 million.

2024 Outlook

As previously disclosed, Pediatrix anticipates that its 2024 Adjusted EBITDA, as defined below, will be in a range of $200 million to $220 million.

For earnings history and earnings-related data on MEDNAX (MD) click here.

You May Also Be Interested In

• Are we witnessing a fundamental or speculative rally in the S&P 500?
• Palo Alto Networks stock dips despite quarterly beat, raised profit outlook
• Morgan Stanley backs Yum Brands, cuts Chipotle rating as growth outlook diverges